In Vitro Studies with UK-18,892, a New Aminoglycoside Antibiotic

The antibacterial activity of UK-18,892, a new semisynthetic aminoglycoside, was examined against aminoglycoside-susceptible and aminoglycoside-resistant clinical isolates of gram-negative bacilli and Staphylococcus aureus. UK-18,892 had a similar degree of activity to those of amikacin and kanamyci...

Celý popis

Podrobná bibliografie

Vydáno v:	Antimicrob Agents Chemother
Hlavní autoři:	Jevons, S., Cheeseman, H. E., Brammer, K. W.
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	American Society for Microbiology (ASM) 1978
Témata:	Physiological Effects and Microbial Susceptibility
On-line přístup:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC352451/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/708005/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.14.3.277
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!